These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15293611)

  • 41. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic.
    Griffiths AL; Jamsen K; Carlin JB; Grimwood K; Carzino R; Robinson PJ; Massie J; Armstrong DS
    Am J Respir Crit Care Med; 2005 May; 171(9):1020-5. PubMed ID: 15709051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
    Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotypic characterisation and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of different hospitals and medical centres in Poland.
    Brzozowski M; Krukowska Ż; Galant K; Jursa-Kulesza J; Kosik-Bogacka D
    BMC Infect Dis; 2020 Sep; 20(1):693. PubMed ID: 32962640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic.
    Griffiths AL; Wurzel DF; Robinson PJ; Carzino R; Massie J
    J Cyst Fibros; 2012 Jan; 11(1):49-52. PubMed ID: 21907639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A diagnostic PCR assay for the detection of an Australian epidemic strain of Pseudomonas aeruginosa.
    Williams HL; Turnbull L; Thomas SJ; Murphy A; Stinear T; Armstrong DS; Whitchurch CB
    Ann Clin Microbiol Antimicrob; 2010 Jul; 9():18. PubMed ID: 20637114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.
    Hafiane A; Ravaoarinoro M
    Pathol Biol (Paris); 2011 Oct; 59(5):e109-14. PubMed ID: 19896303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
    Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
    PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa.
    Pages-Monteiro L; Marti R; Commun C; Alliot N; Bardel C; Meugnier H; Perouse-de-Montclos M; Reix P; Durieu I; Durupt S; Vandenesch F; Freney J; Cournoyer B; Doleans-Jordheim A
    PLoS One; 2017; 12(3):e0173022. PubMed ID: 28282386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic.
    Armstrong DS; Nixon GM; Carzino R; Bigham A; Carlin JB; Robins-Browne RM; Grimwood K
    Am J Respir Crit Care Med; 2002 Oct; 166(7):983-7. PubMed ID: 12359658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.
    Lang AB; Rüdeberg A; Schöni MH; Que JU; Fürer E; Schaad UB
    Pediatr Infect Dis J; 2004 Jun; 23(6):504-10. PubMed ID: 15194830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term clinical outcomes of 'Prairie Epidemic Strain'
    Somayaji R; Lam JC; Surette MG; Waddell B; Rabin HR; Sibley CD; Purighalla S; Parkins MD
    Thorax; 2017 Apr; 72(4):333-339. PubMed ID: 27682327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
    López-Causapé C; de Dios-Caballero J; Cobo M; Escribano A; Asensio Ó; Oliver A; Del Campo R; Cantón R; Solé A; Cortell I; Asensio O; García G; Martínez MT; Cols M; Salcedo A; Vázquez C; Baranda F; Girón R; Quintana E; Delgado I; de Miguel MÁ; García M; Oliva C; Prados MC; Barrio MI; Pastor MD; Olveira C; de Gracia J; Álvarez A; Escribano A; Castillo S; Figuerola J; Togores B; Oliver A; López C; de Dios Caballero J; Tato M; Máiz L; Suárez L; Cantón R
    Int J Antimicrob Agents; 2017 Sep; 50(3):334-341. PubMed ID: 28735882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas Aeruginosa.
    Panagea S; Winstanley C; Parsons YN; Walshaw MJ; Ledson MJ; Hart CA
    Mol Diagn; 2003; 7(3-4):195-200. PubMed ID: 15068391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype.
    Pollini S; Fiscarelli E; Mugnaioli C; Di Pilato V; Ricciotti G; Neri AS; Rossolini GM
    Clin Microbiol Infect; 2011 Aug; 17(8):1272-5. PubMed ID: 21375657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients.
    Ferreira AG; Leão RS; Carvalho-Assef AP; da Silva ÉA; Firmida Mde C; Folescu TW; Paixão VA; Santana MA; de Abreu e Silva FA; Barth AL; Marques EA
    APMIS; 2015 Dec; 123(12):1061-8. PubMed ID: 26522829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis.
    Lee AC; Jones AL
    Paediatr Respir Rev; 2018 Jun; 27():18-20. PubMed ID: 29914746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform.
    Syrmis MW; Moser RJ; Kidd TJ; Hunt P; Ramsay KA; Bell SC; Wainwright CE; Grimwood K; Nissen MD; Sloots TP; Whiley DM
    J Med Microbiol; 2013 May; 62(Pt 5):734-740. PubMed ID: 23412772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.
    Tingpej P; Smith L; Rose B; Zhu H; Conibear T; Al Nassafi K; Manos J; Elkins M; Bye P; Willcox M; Bell S; Wainwright C; Harbour C
    J Clin Microbiol; 2007 Jun; 45(6):1697-704. PubMed ID: 17392437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.